Type 2 Diabetes Trial, Not Yet Recruiting (NCT07198932)

Type 2 Diabetes Trial, Not Yet Recruiting NCT07198932 Sponsor: Yanbing Li Condition: Type 2 Diabetes

Printed from Voxsanity (voxsanity.com.au) — NCT07198932 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Type 2 Diabetes

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You must be willing and able to sign a consent form agreeing to take part in the study.
You must be 18 years old or older.
You must have been diagnosed with type 2 diabetes.
Your recent blood sugar control test (HbA1c) must show a result between 7% and 9%, your fasting blood sugar must be at or below a certain level, and you must have been on a stable insulin treatment (with or without certain diabetes pills) for at least 12 weeks before joining — the specific types of insulin and diabetes pills allowed are limited, so confirm the details with the trial site.
You must be willing to start, or have already started, taking one of two specific diabetes medications (cofrogliptin or linagliptin), as decided by your doctor as part of your normal care, either up to 2 weeks before or up to 2 weeks after signing the consent form.

Who may not be able to join:

You may not be able to join if you have a known allergy to either of the study medications.
You may not be able to join if you have been diagnosed with type 1 diabetes.
You may not be able to join if you are unable to follow the procedures required by the study.
You may not be able to join if you are currently pregnant, planning to become pregnant, or are breastfeeding.
You may not be able to join if the study doctor decides, for any other reason, that the trial is not appropriate for you (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 30 June 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07198932

Sponsor: Yanbing Li

Phase: Not Applicable

Status: Not Yet Recruiting

Condition: Type 2 Diabetes

More information: https://clinicaltrials.gov/study/NCT07198932

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You must be willing and able to sign a consent form agreeing to take part in the study.
You must be 18 years old or older.
You must have been diagnosed with type 2 diabetes.
Your recent blood sugar control test (HbA1c) must show a result between 7% and 9%, your fasting blood sugar must be at or below a certain level, and you must have been on a stable insulin treatment (with or without certain diabetes pills) for at least 12 weeks before joining — the specific types of insulin and diabetes pills allowed are limited, so confirm the details with the trial site.
You must be willing to start, or have already started, taking one of two specific diabetes medications (cofrogliptin or linagliptin), as decided by your doctor as part of your normal care, either up to 2 weeks before or up to 2 weeks after signing the consent form.

Who may not be able to join:

You may not be able to join if you have a known allergy to either of the study medications.
You may not be able to join if you have been diagnosed with type 1 diabetes.
You may not be able to join if you are unable to follow the procedures required by the study.
You may not be able to join if you are currently pregnant, planning to become pregnant, or are breastfeeding.
You may not be able to join if the study doctor decides, for any other reason, that the trial is not appropriate for you (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 30 June 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Not Yet Recruiting

Phase

Not Applicable

Sponsor

Yanbing Li

Registry

ClinicalTrials.gov

Start date

1 October 2025

Est. completion

31 July 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Change in HbA1c

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov